Rockwell Medical Files 8-K on Q4/FY Earnings
Ticker: RMTI · Form: 8-K · Filed: Mar 26, 2026 · CIK: 0001041024
| Field | Detail |
|---|---|
| Company | Rockwell Medical, Inc. (RMTI) |
| Form Type | 8-K |
| Filed Date | Mar 26, 2026 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: earnings, financial-results, 8-K, corporate-filing
TL;DR
**Rockwell Medical just dropped its Q4 and full-year earnings report via an 8-K, so check those numbers!**
AI Summary
Rockwell Medical, Inc. filed an 8-K on March 26, 2026, to report its latest financial results, specifically under Item 2.02, "Results of Operations and Financial Condition." This filing includes an exhibit (EX-99.1) detailing their Q4 and full fiscal year earnings. This matters to investors because it provides the most current financial health update, allowing them to assess the company's performance and make informed decisions about buying, holding, or selling the stock based on actual reported numbers.
Why It Matters
This filing provides crucial financial performance data, directly impacting investor perception and the stock's valuation. It's the latest official word on how the company is doing financially.
Risk Assessment
Risk Level: medium — While an earnings report provides transparency, the actual financial results could introduce new risks or alleviate existing ones, making the overall impact medium until the numbers are analyzed.
Analyst Insight
A smart investor would immediately review the EX-99.1 exhibit to understand the detailed financial results and compare them against analyst expectations and previous periods before making any trading decisions.
Key Players & Entities
- ROCKWELL MEDICAL, INC. (company) — Filer of the 8-K
- 0001041024 (company) — CIK of Rockwell Medical, Inc.
- 2026-03-26 (date) — Filing Date and Period of Report
FAQ
What specific items were reported in this 8-K filing by Rockwell Medical, Inc.?
The 8-K filing by Rockwell Medical, Inc. reported under Item 2.02: Results of Operations and Financial Condition and Item 9.01: Financial Statements and Exhibits, specifically on March 26, 2026.
What is the accession number for this particular 8-K filing?
The SEC Accession No. for this 8-K filing is 0001628280-26-021176, as stated in the filing details.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on March 26, 2026, at 06:10:47.
What document contains the detailed earnings information for Rockwell Medical, Inc.?
The detailed earnings information is contained in Exhibit 99.1, specifically referenced as 'EX-99.1 a2025q4fy-earningsxpr.htm' with a size of 190208 bytes.
What is the business address of Rockwell Medical, Inc. as listed in the filing?
The business address of Rockwell Medical, Inc. is 30142 WIXOM ROAD WIXOM MI 48393, with a phone number of 8004493353.
Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2026-03-26 06:10:47
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 RMTI Nasdaq Capital Market Indicate b
Filing Documents
- rmti-20260326.htm (8-K) — 32KB
- a2025q4fy-earningsxpr.htm (EX-99.1) — 186KB
- image.jpg (GRAPHIC) — 10KB
- 0001628280-26-021176.txt ( ) — 359KB
- rmti-20260326.xsd (EX-101.SCH) — 2KB
- rmti-20260326_lab.xml (EX-101.LAB) — 21KB
- rmti-20260326_pre.xml (EX-101.PRE) — 12KB
- rmti-20260326_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On March 26, 2026, Rockwell Medical, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2025. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. As provided in General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 incorporated in this Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibit is being furnished herewith: EXHIBIT INDEX Exhibit No. Description 99.1 Press release dated March 26, 2026 104 Cover Page Interactive Data File, formatted in INline XBRL and included as Exhibit 101. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROCKWELL MEDICAL, INC. Date: March 26, 2026 By: /s/ Mark Strobeck Mark Strobeck Chief Executive Officer